KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Teladoc Health (TDOC) Depreciation & Amortization (IS) (2016 - 2023)

Teladoc Health (TDOC) has disclosed Depreciation & Amortization (IS) for 10 consecutive years, with $94.3 million as the latest value for Q3 2023.

  • Quarterly Depreciation & Amortization (IS) rose 52.08% to $94.3 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $315.3 million through Sep 2023, up 35.51% year-over-year, with the annual reading at $256.0 million for FY2022, 25.36% up from the prior year.
  • Depreciation & Amortization (IS) hit $94.3 million in Q3 2023 for Teladoc Health, up from $75.5 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $94.3 million in Q3 2023 to a low of $9.6 million in Q1 2019.
  • Historically, Depreciation & Amortization (IS) has averaged $42.5 million across 5 years, with a median of $51.3 million in 2021.
  • Biggest five-year swings in Depreciation & Amortization (IS): dropped 1.32% in 2019 and later soared 418.96% in 2021.
  • Year by year, Depreciation & Amortization (IS) stood at $9.9 million in 2019, then surged by 273.82% to $37.0 million in 2020, then surged by 41.59% to $52.3 million in 2021, then surged by 44.68% to $75.7 million in 2022, then increased by 24.55% to $94.3 million in 2023.
  • Business Quant data shows Depreciation & Amortization (IS) for TDOC at $94.3 million in Q3 2023, $75.5 million in Q2 2023, and $69.8 million in Q1 2023.